A share price of Zimmer Biomet Holdings Inc [ZBH] is currently trading at $94.08, up 1.52%. An important factor to consider is whether the stock is rising or falling in short-term value. The ZBH shares have gain 4.63% over the last week, with a monthly amount glided 1.43%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Zimmer Biomet Holdings Inc [NYSE: ZBH] stock has seen the most recent analyst activity on January 06, 2026, when Raymond James downgraded its rating to a Mkt Perform. Previously, Evercore ISI upgraded its rating to Outperform on January 05, 2026, and kept the price target unchanged to $210. On December 16, 2025, downgrade downgraded it’s rating to Neutral but maintained its price target of $100 on the stock. JP Morgan downgraded its rating to a Neutral but stick to its price target of $100 on November 06, 2025. Rothschild & Co Redburn initiated its recommendation with a Buy and recommended $130 as its price target on September 18, 2025. Roth Capital upgraded its rating to Buy for this stock on July 15, 2025, but kept the price target unchanged to $135. In a note dated December 17, 2024, JP Morgan upgraded an Overweight rating on this stock and boosted its target price from $125 to $128.
Zimmer Biomet Holdings Inc experienced fluctuations in its stock price throughout the past year between $85.33 and $114.44. Currently, Wall Street analysts expect the stock to reach $111.78 within the next 12 months. Zimmer Biomet Holdings Inc [NYSE: ZBH] shares were valued at $94.08 at the most recent close of the market. An investor can expect a potential return of 18.81% based on the average ZBH price forecast.
Analyzing the ZBH fundamentals
Trailing Twelve Months sales for Zimmer Biomet Holdings Inc [NYSE:ZBH] were 8.01B which represents 9.71% growth. Gross Profit Margin for this corporation currently stands at 0.71% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.1%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.06 and Total Capital is 0.06. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.57.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 92.26 points at the first support level, and at 90.44 for the second support level. However, for the 1st resistance point, the stock is sitting at 95.42, and for the 2nd resistance point, it is at 96.76.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Zimmer Biomet Holdings Inc [NYSE:ZBH] is 2.43. On the other hand, the Quick Ratio is 1.39, and the Cash Ratio is 0.72. Considering the valuation of this stock, the price to sales ratio is 2.33, the price to book ratio is 1.46 and price to earnings (TTM) ratio is 23.28.
Transactions by insiders
Recent insider trading involved Yi Sang, Group President, Asia Pacific, that happened on Sep 11 ’25 when 1200.0 shares were sold. Officer, Yi Sang completed a deal on Sep 11 ’25 to buy 1200.0 shares. Meanwhile, SVP and CHRO Winkler Lori sold 1500.0 shares on Sep 08 ’25.
